SEC Form 4 · accession 0001140361-16-058352
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Rice
Officer — President & CEO · Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 8:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 15, 2016 | A | 100,000 | $0.00 | A | 120,767 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.90 | Mar 15, 2016 | A | 100,000 | A | — | Mar 15, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The restricted stock vests 25% on the grant date and thereafter, in 36 equal monthly installments.
- F2The options vest 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments.